Safety and Tolerability of KarXT (Xanomeline–Trospium) in a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study in Patients With Schizophrenia 

Correll CU, et al. Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia. Schizophrenia. 2022;8:109.